Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP186300.RAbjNEX6XgYg_txVHO0mdIuDMKoq1mkjg0yIJQ0_v_VAc130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186300.RAbjNEX6XgYg_txVHO0mdIuDMKoq1mkjg0yIJQ0_v_VAc130_provenance.
• NP284535.RAlsKaO2D_kjILnluZgyztSmb_XLPzaYLv0s5TreTEn24130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284535.RAlsKaO2D_kjILnluZgyztSmb_XLPzaYLv0s5TreTEn24130_provenance.
• NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909105.RAZs0pLm_j9Sja99lTL_iu1c7fArRrJMpPffbHg2_djlA130_provenance.
• NP421362.RAFCC-V6Kfi1CTPk-yNC8Ng0OjxWxBKFmEvyHq966kVDk130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421362.RAFCC-V6Kfi1CTPk-yNC8Ng0OjxWxBKFmEvyHq966kVDk130_provenance.
• NP659220.RALiH-sZ10QIIJgHnQsvjuNnSDA-iptsTjA6xZe7M3RMQ130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659220.RALiH-sZ10QIIJgHnQsvjuNnSDA-iptsTjA6xZe7M3RMQ130_provenance.
• assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP907981.RAWCbEvQdWGiEmLBZYvwW9-F6ZCn0x22No_rOD6SXhRRY130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907981.RAWCbEvQdWGiEmLBZYvwW9-F6ZCn0x22No_rOD6SXhRRY130_provenance.
• NP744566.RAEtus0JnhFRAcA_Mppb-FFggFZdvPhOeODkWZXLxszEU130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP744566.RAEtus0JnhFRAcA_Mppb-FFggFZdvPhOeODkWZXLxszEU130_provenance.
• NP783984.RAjnani2mmePIAbpIQwfOxGXnqKVWUDKCey16MAT3bD_o130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783984.RAjnani2mmePIAbpIQwfOxGXnqKVWUDKCey16MAT3bD_o130_provenance.
• NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783964.RAIbuK6wAMV3-2UafgVFsiwmfM_AyUdIopr7cedgA-7Z0130_provenance.
• NP784001.RAIASCp_FNl_VtshE7OgCWISFmnNcMXKVJ5vY7AywEyjQ130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784001.RAIASCp_FNl_VtshE7OgCWISFmnNcMXKVJ5vY7AywEyjQ130_provenance.
• NP783978.RA6Dou-3VpwqZYglFrYn7SDAq9sMZQnb_aiAwrIdJm8gc130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783978.RA6Dou-3VpwqZYglFrYn7SDAq9sMZQnb_aiAwrIdJm8gc130_provenance.
• NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_assertion description "[Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907982.RA8s_UdE4sCw-INtVmb8usbZID8w7qFuz9kNFDgBNWZsE130_provenance.